Search results for: 'electrode active material'
- Did you mean
- electrodes active material
- electron active material
- Related search terms
- Materials and Chemicals Research Service--Advanced Materials Technology (Technical Insights)
- Material Innovations for Electronic Skin, Solar Fuels, Skincare, Construction and Healthcare Industries
- active pharmaceutical ingredients market
- material handling equipment industry in the Mid-Atlantic region
- material analysi market
-
17 Mar 2025  |  Global  |  Technology Research
Innovations in Restorative Dentistry
Advancements in Hybrid Composites, Smart Materials, and Digital Technologies Transforming the Restorative Dentistry Market
Technology is transforming the field of dentistry, driven by continuous advancements in dental materials and 3D printing aimed at improving the appearance, functionality, and durability of dental restorations. Emerging dental materials such as hybrid composites and smart composites, as well as digital technologies, including 3D printing and CAD/CAM...
$4,950.00
Special Price $4,455.00 save 10 %
-
23 Sep 2026  |  Global  |  Technology Research
Programmable Epigenome Editing for Disease Reversal
Epigenome editing is building a stronger translational foundation, but its broader adoption will depend on solving delivery, targeting and long-term control
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applications shaping the field. It assesses the competitive...
$4,950.00 -
31 Jul 2025  |  Global  |  Technology Research
Growth Opportunities in RNA Therapeutics
Broad Applications Drive Growth in RNA Therapeutics
The report analyzes clinical trial activity across RNA therapeutic classes, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASO), aptamers, micro RNA (miRNA), self-amplifying RNA (saRNA), small-activating RNA (RNAa), and circular RNA (cirRNA). It highlights key players in each segment and their role in adv...
$4,950.00 -
21 Mar 2025  |  Global  |  Market Research
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...
$4,950.00
Special Price $4,455.00 save 10 %
-
16 Aug 2016  |  North America  |  Market Research
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
Emerging Business Models Drive Transformation
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to comme...
$7,000.00
Special Price $5,250.00 save 25 %
-
05 Nov 2025  |  Global  |  Market Research
Global Pharmacovigilance and Safety Testing Outsourcing Services Market, Forecast to 2030
A Growing Focus on Precision Medicine and a Converging Ecosystem of Service Providers is Driving Market Growth
The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...
$4,950.00 -
02 Dec 2025  |  Global  |  Frost Radar
Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...
$4,950.00 -
27 May 2016  |  Africa  |  Market Research
Pharmaceutical Market Access Strategy for Ethiopia
Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain
Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Dec 2025  |  Europe  |  Market Outlook
Top 10 Growth Opportunities in the European Life Sciences Industry, 2026
Transformational Policies Will Unlock Life Sciences Growth in 2026 Through AI-Enabled Innovation, Digital-Clinical Scale-Up, and Biomanufacturing Resilience
Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...
$2,450.00 -
31 Jul 2026  |  Global  |  Market Research
Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031
Expansion in Sterile Fill-Finish and ADC-Payload-Linkers Capabilities Will Meet Critical Demand for High-Value Injectables
The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...
$2,450.00